BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34470475)

  • 1. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
    Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
    J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
    Ades S; Douce D; Holmes CE; Cory S; Prior S; Butenas S; Callas P; Cushman M
    J Thromb Haemost; 2018 Jun; 16(6):1099-1106. PubMed ID: 29575637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
    Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
    J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
    Schorling RM; Pfrepper C; Golombek T; Cella CA; Muñoz-Unceta N; Siegemund R; Engel C; Petros S; Lordick F; Knödler M
    Oncol Res Treat; 2020; 43(9):414-427. PubMed ID: 32580190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.
    Eichinger S; Heinze G; Kyrle PA
    J Am Heart Assoc; 2014 Jan; 3(1):e000467. PubMed ID: 24385451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.
    Sánchez-López V; Marín-Romero S; Ferrer-Galván M; Elías-Hernández T; Lobo Beristain JL; Ballaz Quincoces A; Jara-Palomares L; Rodríguez Martorell FJ; Castro MJ; Marín Hinojosa C; López-Campos JL; Otero-Candelera R
    Am J Clin Pathol; 2024 May; 161(5):501-511. PubMed ID: 38340336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty.
    Yukizawa Y; Inaba Y; Watanabe S; Yajima S; Kobayashi N; Ishida T; Iwamoto N; Choe H; Saito T
    Acta Orthop; 2012 Feb; 83(1):14-21. PubMed ID: 22248164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.
    Moik F; Posch F; Grilz E; Scheithauer W; Pabinger I; Prager G; Ay C
    Thromb Res; 2020 Mar; 187():9-17. PubMed ID: 31945589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
    Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
    J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing risk of venous thromboembolism in the patient with cancer.
    Khorana AA; Connolly GC
    J Clin Oncol; 2009 Oct; 27(29):4839-47. PubMed ID: 19720906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study.
    Stender MT; Larsen TB; Sørensen HT; Thorlacius-Ussing O
    J Thromb Haemost; 2012 Oct; 10(10):2027-31. PubMed ID: 22900573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
    Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
    Man YN; Wang YN; Hao J; Liu X; Liu C; Zhu C; Wu XZ
    Int J Gynecol Cancer; 2015 Jan; 25(1):24-32. PubMed ID: 25347092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers and venous thromboembolism.
    Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):332-6. PubMed ID: 19228607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
    Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
    J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
    Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
    J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.